A vaccine to protect against Campylobacter jejuni was recently approved for human clinical trials by the U.S. Food and Drug Administration. Campylobacter is a major cause of bacterial diarrhea worldwide — estimated to be the cause of 4-15 percent of cases. It’s a problem in both developed and developing countries and is associated with unpasteurized…

If a disease outbreak occurs in today’s interconnected global economy, the stakes are higher than usual: Expect lost domestic and international sales, a damaged reputation, and even a hit to the U.S. economy from lost trade and employment. The desired outcome, of course, is to prevent disease outbreaks with strong biosecurity plans. Are today’s plans…

Until recently, rotavirus was the leading cause of gastrointestinal illness in young children in the United States. Before a vaccine was developed for the virus in 2006, “almost all children in the United States were infected with rotavirus before their 5th birthday,” according to the Centers for Disease Control and Prevention (CDC).  Now, a

Scientists have begun a clinical trial of two vaccines that may prevent Shigella infection, announced the National Institutes of Health Wednesday. The government-funded study will examine the effect of two different but related vaccines on 90 healthy adults ages 18 to 45 years old. Shigellosis, the disease caused by infection with Shigella bacteria, is an…

The United Kingdom’s mass poultry vaccinations introduced to combat Salmonella infections have led to a dramatic fall in the number of cases since the late 1990s, according to a researcher at the University of Liverpool. Salmonella are dangerous foodborne bacteria that affect people worldwide, causing diarrhea, vomiting, nausea, fever and abdominal pain. The European Union…

The recent largest beef recall in Canadian history and its resulting economic and health consequences illustrates the complexities and difficulties associated with Canadian beef safety. However, there is currently a simple, unused, practical and economically viable solution to avoiding such beef recalls as well as preventing E. coli O157 outbreaks — we should vaccinate cattle…

A Canadian vaccine designed to reduce E. coli O157:H7 shedding in cattle has become the first drug of its kind to be approved for use in the United Kingdom. The medication – manufactured by Bioniche Life Sciences, Inc. – was granted a Special Treatment Certificate (STC) by the UK’s Veterinary Medical Directorate, a branch of…

Vaccinating cattle for E. coli O157:H7 has, in theory, long been a favorite pre-harvest intervention strategy for consumers, and now Kansas State University has found it appears to work. K State has found a commercial vaccine for cattle can effectively reduce levels of E. coli by more than 50 percent by using two doses rather…